HU280-02 - Bioethics
Valana Nicole Rotundo
March 2014
The advance of medical science within the past two hundred years is nothing short of astounding. During the 1960s, the topic of improved disease treatment was initially introduced (Walters, 2012). The advent of the permanent integration of genetics within the ideology of bioethics came in 1972. A primary determinant in understanding the genetic aspects of human disease is the Human Genome Project, which has been taking tremendous strides toward progressions for diagnostic procedures, treatment methods, and preventive measures ("Human Genome Project," 2013). Of course, any new discovery breeds debate. Since its introduction, the moral …show more content…
As applied to the opposition, the risks that come with genetic research could be so substantial that society would ultimately enjoy more benefits without it. There would be no concerns about mutations, and no GMO fiasco. However, humanity could stand to reap the benefits of the considerable advances resulting from genetic research. Advanced diagnostic procedures and disease treatment will improve the health of the population as a whole. To satisfy both sides, research could continue, but under strict guidelines. Any genetically modified consumables must be grown within isolated parameters, to ensure that they cannot leach into the natural environment. Comprehensive testing must be completed, and any experiments proven unsafe for humans and the environment must not be reproduced for public …show more content…
(2013). National Institutes of Health. Retrieved from http://report.nih.gov/NIHfactsheets/ViewFactSheet.aspx?csid=45&key=H#H
Plants. (2014). GMO Compass. Retrieved from http://www.gmo-compass.org/eng/database/plants/
Schanker, B. (2010). Relativistic perspectives of genetic enhancement: a challenge to future progress. American Journal of Bioethics, 10(4), 74-76. doi: 10.1080/15265161003633011
Steinbock, B., London, A., & Arras, J. (2013). Ethical issues in modern medicine: contemporary readings in bioethics (8th ed). New York, NY: McGraw-Hill.
Use of Antibiotic Resistance Marker Genes in Transgenic Plants. (1998). U.S. Food and Drug Administration. Retrieved from http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/Biotechnology/ucm096135.htm
Walters, L. (2012). Genetics and bioethics: how our thinking has changed since 1969. Theoretical Medicine And Bioethics, 33(1), 83-95. doi: 10.1007/s11017-012-9210-8
Why Antibiotic Resistance Genes? (2013). GMO Compass. Retrieved from